Lumibird SA (EPA:LBIRD)
France · Delayed Price · Currency is EUR 26.05
-0.10 (-0.38%)
Aug 21, 2026, 5:35 PM CET
Lumibird Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 228.53 | 228.53 | 210.06 | 206.55 | 194.29 | 166.39 |
Revenue Growth | 4.30% | 8.79% | 1.70% | 6.31% | 16.77% | 28.48% |
Gross Profit Gross Profit Growth | 144.79 | 144.79 | 132.37 | 128.11 | 120.42 | 105.98 |
Operating Income Operating Income Growth | 25.65 | 25.65 | 14.9 | 18.4 | 16.36 | 19.76 |
Net Income Net Income Growth | 14.01 | 14.01 | 5.7 | 7.13 | 11.35 | 13.86 |
Earnings Per Share EPS Growth | 0.64 | 0.64 | 0.26 | 0.32 | 0.51 | 0.62 |
EPS Growth | 30.56% | 144.60% | -18.75% | -37.26% | -17.74% | 106.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Photonic Photonic Growth | 113.41 | 113.41 | 99.37 | 100.8 | 93.51 | 76.36 |
Medical Medical Growth | 112.21 | 112.21 | 107.75 | 102.76 | 97.45 | 86.11 |
Total Total Growth | 225.62 | 225.62 | 207.12 | 203.56 | 190.96 | 162.47 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 61.7 | 61.7 | 71.27 | 56.31 | 61.86 | 97.13 |
Total Debt Total Debt Growth | 146.19 | 146.19 | 161.07 | 145.08 | 114.18 | 112.03 |
Net Cash (Debt) Net Cash Growth | -84.48 | -84.48 | -89.8 | -88.76 | -52.32 | -14.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.84 | -3.84 | -4.10 | -3.99 | -2.35 | -0.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 29 | 29 | 34.37 | 20.67 | 1.43 | 26.58 |
Capital Expenditures CapEx Growth | -16.36 | -16.36 | -22.96 | -25.55 | -29.45 | -20.11 |
Free Cash Flow Free Cash Flow Growth | 12.64 | 12.64 | 11.41 | -4.89 | -28.02 | 6.47 |
Free Cash Flow Growth | 146.28% | 10.85% | - | - | - | 766.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.36% | 63.36% | 63.02% | 62.02% | 61.98% | 63.70% |
Operating Margin | 11.22% | 11.22% | 7.09% | 8.91% | 8.42% | 11.88% |
Pretax Margin | 8.29% | 8.29% | 3.11% | 3.61% | 7.43% | 10.58% |
Profit Margin | 6.13% | 6.13% | 2.71% | 3.45% | 5.84% | 8.33% |
FCF Margin | 5.53% | 5.53% | 5.43% | -2.37% | -14.42% | 3.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 40.96 | 33.33 | 36.16 | 37.83 | 32.59 | 38.51 |
Forward PE | 25.73 | 22.11 | 18.18 | 19.89 | 20.70 | 29.04 |
P/FCF Ratio | 45.46 | 36.92 | 18.05 | - | - | 82.50 |
PS Ratio | 2.52 | 2.04 | 0.98 | 1.31 | 1.90 | 3.21 |